Freedom From Diabetes Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-06-2024
- Paid Up Capital ₹ 0.12 M
as on 23-06-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -31.36%
(FY 2023)
- Profit -105.15%
(FY 2023)
- Ebitda -110.00%
(FY 2023)
- Net Worth -1.76%
(FY 2023)
- Total Assets -5.56%
(FY 2023)
About Freedom From Diabetes
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurang Gandhi and Pramod Tripathi serve as directors at the Company.
- CIN/LLPIN
U85310PN2017PTC168827
- Company No.
168827
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Freedom From Diabetes?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurang Gandhi  | Director | 03-Mar-2022 | Current |
| Pramod Tripathi | Director | 10-Feb-2017 | Current |
Financial Performance of Freedom From Diabetes.
Freedom From Diabetes Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.36% decrease. The company also saw a substantial fall in profitability, with a 105.15% decrease in profit. The company's net worth dipped by a decrease of 1.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Freedom From Diabetes?
In 2023, Freedom From Diabetes had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Pramod Tripathi's Freedom From Diabetes LlpActive 1 year 1 monthPramod Tripathi is a mutual person
- Dr. Pramod Tripathi's Health Technology Private LimitedActive 2 years 7 months
Pramod Tripathi is a mutual person
- Dr Pramod Tripathi's Freedom From Lifestyle Disorders Private LimitedActive 2 years 8 months
Pramod Tripathi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Freedom From Diabetes?
Freedom From Diabetes has a workforce of 80 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Freedom From Diabetes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Freedom From Diabetes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
